Sight Sciences, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US82657M1053

USD

5.28

0.27 (5.39%)

Jun 18

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bioventus, Inc.

Butterfly Network, Inc.

908 Devices, Inc.

Sight Sciences, Inc.

Axogen, Inc.

Standard BioTools, Inc.

Semler Scientific, Inc.

TELA Bio, Inc.

Harvard Bioscience, Inc.

Celcuity, Inc.

Jin Medical International Ltd.

Why is Sight Sciences, Inc. ?

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 23.65%, its profits have risen by 22.4%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

22.86%

EBIT Growth (5y)

-3.26%

EBIT to Interest (avg)

-12.78

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.88

Sales to Capital Employed (avg)

0.62

Tax Ratio

0.53%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

50.41%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.28

EV to EBIT

-4.27

EV to EBITDA

-4.32

EV to Capital Employed

12.42

EV to Sales

2.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-290.93%

ROE (Latest)

-60.10%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at USD -17.14 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 7.95 times

RAW MATERIAL COST(Y)

Fallen by 0.02% (YoY

-4What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -12.97 MM has Fallen at -35.04%

NET PROFIT(Q)

At USD -12.98 MM has Fallen at -35.12%

Here's what is working for Sight Sciences, Inc.

Debtors Turnover Ratio

Highest at 7.95 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by 0.02% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sight Sciences, Inc.

Pre-Tax Profit

At USD -12.97 MM has Fallen at -35.04%

over average net sales of the previous four periods of USD -9.6 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -12.98 MM has Fallen at -35.12%

over average net sales of the previous four periods of USD -9.61 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)